From: Impact of COVID-19 on ophthalmic surgical procedures in sub-Saharan Africa: a multicentre study
Region | IRR | 95%CI | p value |
---|---|---|---|
Sub-Saharan Africa | |||
 Cataract | 0.44 | 0.35–0.55 | < 0.001 |
 Cornea | 0.38 | 0.29–0.51 | < 0.001 |
 Glaucoma | 0.72 | 0.52–1.01 | 0.061 |
 Oncology | 0.71 | 0.48–1.05 | 0.087 |
 Orbital/oculoplastic | 0.50 | 0.36–0.69 | < 0.001 |
 Strabismus | 0.19 | 0.11–0.32 | < 0.001 |
 Trauma | 0.90 | 0.63–1.28 | 0.562 |
 Vitreoretinal | 0.67 | 0.42–1.08 | 0.099 |
 Other | 0.71 | 0.49–1.02 | 0.065 |
West Africa | |||
 Cataract | 0.73 | 0.54–0.99 | 0.043 |
 Cornea | 0.41 | 0.27–0.63 | < 0.001 |
 Glaucoma | 0.81 | 0.46–1.40 | 0.447 |
 Oncology | 0.60 | 0.31–1.14 | 0.118 |
 Orbital/oculoplastic | 0.72 | 0.47–1.11 | 0.133 |
 Strabismus | 1.50 | 0.68–3.30 | 0.313 |
 Trauma | 1.25 | 0.81–1.92 | 0.302 |
 Vitreoretinal | 0.82 | 0.39–1.75 | 0.607 |
 Other | 0.73 | 0.41–1.31 | 0.295 |
Central Africa | |||
 Cataract | 0.48 | 0.23–0.98 | 0.045 |
 Cornea | 0.64 | 0.22–1.86 | 0.407 |
 Glaucoma | 1.01 | 0.46–2.22 | 0.977 |
 Oncology | 0.83 | 0.51–1.32 | 0.424 |
 Orbital/oculoplastic | 0.75 | 0.33–1.68 | 0.48 |
 Strabismus | 0.44 | 0.18–1.11 | 0.083 |
 Trauma | 0.79 | 0.48–1.28 | 0.337 |
 Vitreoretinal | 0.72 | 0.08–6.79 | 0.772 |
 Other | 0.51 | 0.19–1.39 | 0.192 |
East Africa | |||
 Cataract | 0.49 | 0.31–0.78 | 0.002 |
 Cornea | 0.88 | 0.16–4.95 | 0.880 |
 Glaucoma | 0.30 | 0.04–2.17 | 0.233 |
 Oncology | 2.0 | 0.18–22.1 | 0.571 |
 Orbital/oculoplastic | 8.5 | 1.42–50.7 | 0.019 |
 Strabismus | 0 | 0 | 0 |
 Trauma | 4 | 1.3–12.2 | 0.015 |
 Vitreoretinal | 0 | 0 | 0 |
 Other | 0 | 0 | 0 |
Southern Africa | |||
 Cataract | 0.29 | 0.20–0.42 | < 0.001 |
 Cornea | 0.29 | 0.20–0.42 | < 0.001 |
 Glaucoma | 0.57 | 0.35–0.91 | 0.019 |
 Oncology | 0.71 | 0.43–1.17 | 0.173 |
 Orbital/oculoplastic | 0.40 | 0.26–0.62 | < 0.001 |
 Strabismus | 0.03 | 0.01–0.06 | < 0.001 |
 Trauma | 0.88 | 0.54–1.43 | 0.597 |
 Vitreoretinal | 0.58 | 0.34–0.99 | 0.045 |
 Other | 0.68 | 0.41–1.12 | 0.126 |